A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection

NCT04544215 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
SUSPENDED
Status
60
Enrollment
OTHER
Sponsor class

Stopped Due to the COVID-19 pandemic, patient enrollment was slower than expected. After enrolling 26 patients, the trial was suspended as our partner company stopped producing haMPC-Exos.

Conditions

Interventions

Sponsor

Ruijin Hospital

Collaborators